Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThis is a minor revision update (from v3.3.3 to v3.3.4) and does not alter any study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a general 'Locations' section and explicitly listed Massachusetts as a location; removed the previously listed 'Massachusetts Locations' entry. Updated the site footer by removing the 'HHS Vulnerability Disclosure' link and changed the page revision to v3.3.3.SummaryDifference0.2%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no other content changes to the study details were observed.SummaryDifference0.1%

- Check59 days agoChange DetectedRemoved the banner about a lapse in government funding and potential delays in updates. This site-wide notice is not part of the study details.SummaryDifference0.4%

- Check73 days agoChange DetectedNo significant updates detected to the study details page between the two screenshots. The content and structure appear unchanged.SummaryDifference0.5%

- Check101 days agoChange Detected- Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. Overall, the page now communicates current operating status and a newer version rather than the old one.SummaryDifference3%

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.